These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 38522946

  • 1. Prolonged duration of action of suxamethonium in pregnant and postpartum patients: A registry study.
    Dalsten H, Crone V, Steinmetz J, Rosager CL, Rasmussen LS, Vested M.
    Acta Anaesthesiol Scand; 2024 Jul; 68(6):737-744. PubMed ID: 38522946
    [Abstract] [Full Text] [Related]

  • 2. Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene.
    Wichmann S, Færk G, Bundgaard JR, Gätke MR.
    Pharmacogenet Genomics; 2016 Jul; 26(7):351-6. PubMed ID: 27031121
    [Abstract] [Full Text] [Related]

  • 3. [Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
    Eskildsen KZ, Gätke MR.
    Ugeskr Laeger; 2014 Mar 17; 176(12A):. PubMed ID: 25350885
    [Abstract] [Full Text] [Related]

  • 4. [Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
    Eskildsen KZ, Gätke MR.
    Ugeskr Laeger; 2015 Apr 27; 177(18):866-8. PubMed ID: 26539575
    [Abstract] [Full Text] [Related]

  • 5. Timing of blood sampling for butyrylcholinesterase phenotyping in patients with prolonged neuromuscular block after mivacurium or suxamethonium.
    Mintjens N, Brummans R, Soetens F, Claes KBM, Vanlinthout LE.
    Acta Anaesthesiol Scand; 2021 Feb 27; 65(2):182-187. PubMed ID: 33010031
    [Abstract] [Full Text] [Related]

  • 6. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia.
    Gätke MR, Bundgaard JR, Viby-Mogensen J.
    Pharmacogenet Genomics; 2007 Nov 27; 17(11):995-9. PubMed ID: 18075469
    [Abstract] [Full Text] [Related]

  • 7. Characterization of a novel BCHE "silent" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.
    Delacour H, Lushchekina S, Mabboux I, Bousquet A, Ceppa F, Schopfer LM, Lockridge O, Masson P.
    PLoS One; 2014 Nov 27; 9(7):e101552. PubMed ID: 25054547
    [Abstract] [Full Text] [Related]

  • 8. Screening patients with prolonged neuromuscular blockade after succinylcholine and mivacurium.
    Cerf C, Mesguish M, Gabriel I, Amselem S, Duvaldestin P.
    Anesth Analg; 2002 Feb 27; 94(2):461-6, table of contents. PubMed ID: 11812719
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phenotype and genotype characteristics of 58 patients showing a prolonged effect of succinylcholine: A four-year experience.
    Millet C, Plaud B, Delacour H.
    Anaesth Crit Care Pain Med; 2021 Apr 27; 40(2):100847. PubMed ID: 33774263
    [Abstract] [Full Text] [Related]

  • 11. Characterization of four BCHE mutations associated with prolonged effect of suxamethonium.
    Brazzolotto X, Courcelle S, Sauvanet C, Guillon V, Igert A, Kononchik J, Nachon F, Ceppa F, Delacour H.
    Pharmacogenomics J; 2021 Apr 27; 21(2):165-173. PubMed ID: 33024248
    [Abstract] [Full Text] [Related]

  • 12. [Prolonged neuromuscular block in a patient with butyrylcholinesterase deficiency].
    Mabboux I, Hary B, Courcelle S, Ceppa F, Delacour H.
    Arch Pediatr; 2016 May 27; 23(5):497-500. PubMed ID: 27017361
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Premature awakening and underuse of neuromuscular monitoring in a registry of patients with butyrylcholinesterase deficiency.
    Thomsen JL, Nielsen CV, Palmqvist DF, Gätke MR.
    Br J Anaesth; 2015 Jul 27; 115 Suppl 1():i89-i94. PubMed ID: 26174307
    [Abstract] [Full Text] [Related]

  • 16. How important is the butyrylcholinesterase level for cesarean section?
    Inangil G, Deniz S, Kurt YG, Keskin U, Bakal O, Sen H, Ozkan S, Kurt E.
    Pregnancy Hypertens; 2016 Jan 27; 6(1):26-9. PubMed ID: 26955768
    [Abstract] [Full Text] [Related]

  • 17. Cholinesterase unit establishment and issuing of >>Warning Cards<< for carriers of suxamethonium sensitive serum butyrylcholinesterase variants.
    Surina B, Nosso D, Siftar Z, Flegar-Mestrić Z, Simeon-Rudolf V.
    Coll Antropol; 2004 Jan 27; 28 Suppl 2():297-304. PubMed ID: 15571104
    [Abstract] [Full Text] [Related]

  • 18. [Plasma cholinesterase and abnormal reaction to suxamethonium injection. 20-year experience with the Danish Cholinesterase Registry].
    Jensen FS, Mogensen JV.
    Ugeskr Laeger; 1996 Mar 25; 158(13):1835-9. PubMed ID: 8650760
    [Abstract] [Full Text] [Related]

  • 19. Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population.
    Yen T, Nightingale BN, Burns JC, Sullivan DR, Stewart PM.
    Clin Chem; 2003 Aug 25; 49(8):1297-308. PubMed ID: 12881446
    [Abstract] [Full Text] [Related]

  • 20. Genotyping the butyrylcholinesterase in patients with prolonged neuromuscular block after succinylcholine.
    Levano S, Ginz H, Siegemund M, Filipovic M, Voronkov E, Urwyler A, Girard T.
    Anesthesiology; 2005 Mar 25; 102(3):531-5. PubMed ID: 15731589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.